FDA issued a Warning Letter to Baxter Healthcare Corporation on 5/31/2013 for a previous inspection.
483 Baxter Healthcare Dec 2018

483 Baxter Healthcare Dec 2018

Laurimer Kuilan-Torres FDA, Miguel Martinez FDA, Jose Melendez FDA$119.00 - Available Now

FDA investigators audited the Baxter Healthcare - Jayuya, PR, United States facility and issued inspectional observations (via FDA 483) on 21 Dec 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 21 Dec 2018
  • Location: Jayuya, United States
  • FEI: 2618677
Add To Cart